Log In
Print
BCIQ
Print
Print this Print this
 

EPZ5687

  Manage Alerts
Collapse Summary General Information
Company Epizyme Inc.
DescriptionEZH2 inhibitor
Molecular Target Enhancer of zeste homolog 2 (EZH2)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationNon-Hodgkin's lymphoma (NHL)
Indication DetailsTreat non-Hodgkin's lymphoma (NHL)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today